Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients: A Randomized, Double-blind, Placebo-controlled Study

NCT04242004 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04242004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04242004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients: A Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
Fudan University
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 30, 2019
Completion date
May 1, 2020
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurocognitive impairment